Evidence map›Paper›PMID 23978307›Full record

ArticleVeterinary immunology and immunopathology2013

The equine alveolar macrophage: functional and phenotypic comparisons with peritoneal macrophages.

Anna E Karagianni, Ronan Kapetanovic, Bruce C McGorum, David A Hume, Scott R Pirie

Open access · greenAbstract readComparative Study
In one paragraph

Article in Veterinary immunology and immunopathology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Kynurenine Pathway in Respiratory Diseases.International journal of tryptophan research : IJTR · 2024
    Review
  5. Article
  6. Gene Expression Profiles of the Immuno-Transcriptome in Equine Asthma.Animals : an open access journal from MDPI · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Alveolar macrophage phenotypes in severe equine asthma.Veterinary journal (London, England : 1997) · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Anna E KaragianniThe Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian EH25 9PS, UK. Electronic address: anna.karagianni@roslin.ed.ac.uk.
Ronan Kapetanovic
Bruce C McGorum
David A Hume
Scott R Pirie
University of Edinburgh · GBRoslin Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/G004013/1
6 · The paper itself

Abstract

Alveolar macrophages (AMs) constitute the first line of defence in the lung of all species, playing a crucial role in the regulation of immune responses to inhaled pathogens. A detailed understanding of the function and phenotype of AMs is a necessary pre-requisite to both elucidating their role in preventing opportunistic bacterial colonisation of the lower respiratory tract and developing appropriate preventative strategies. The purpose of the study was to characterise this important innate immune cell at the tissue level by making functional and phenotypic comparisons with peritoneal macrophages (PMs). We hypothesised that the tissue of origin determines a unique phenotype of AMs, which may constitute an appropriate therapeutic target for certain equine respiratory diseases. Macrophages isolated from the lung and the peritoneal cavity of 9 horses were stimulated with various toll like receptor (TLR) ligands and the production of nitrite, tumour necrosis factor alpha (TNFα), interleukin (IL) 10 and indoleamine 2,3-dioxygenase (IDO) were measured by the Griess reaction and enzyme linked immunosorbent assay (ELISA) and/or quantitative polymerase chain reaction, respectively. Cells were also compared on the basis of phagocytic-capacity and the expression of several cell surface markers. AMs, but not PMs, demonstrated increased TNFα release following stimulation with LPS, polyinosinic polycytidylic acid (Poly IC) and heat-killed Salmonella typhinurium and increased TNFα and IDO mRNA expression when stimulated with LPS. AMs showed high expression of the specific macrophage markers cluster of differentiation (CD) 14, CD163 and TLR4, whereas PMs showed high expression of TLR4 only. AMs, but not PMs, demonstrated efficient phagocytic activity. Our results demonstrate that AMs are more active than PMs when stimulated with various pro-inflammatory ligands, thus supporting the importance of the local microenvironment in the activation status of the macrophage. This information provides a valuable knowledge base on which to improve our understanding of the role of macrophages and their microenvironment in equine innate immunity.

Indexed as

AnimalsFlow CytometryHorsesImmunity, InnateImmunophenotypingIndoleamine-Pyrrole 2,3,-DioxygenaseInterleukin-10LungMacrophages, AlveolarMacrophages, PeritonealNitratesPhenotypeReverse Transcriptase Polymerase Chain ReactionRNATumor Necrosis Factor-alphaIndoleamine-Pyrrole 2,3,-DioxygenaseInterleukin-10NitratesRNATumor Necrosis Factor-alphaalveolar macrophagesAMsBALFbronchoalveolar lavage fluidCDcDNAcluster of differentiationcomplementary DNAforward scatterFSHorsehorse serumHSIADImmunityinflammatory airway diseaseLungsMacrophageMD2myeloid differentiation factor 2nitric oxideNOPeritoneal cavityperitoneal lavageperitoneal macrophagesPLPMsPoly ICpolyinosinic polycytidylic acidqPCRquantitative PCRRINRNA integrity numberRoswell Park Memorial InstituteRPMISCside scatterTLRtoll-like receptor

Identifiers

PMID23978307
PMCPMC3795452
OpenAlexW2133413068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.